Last reviewed · How we verify

NCT04847609: FollowAir

GentleCath Air (Urinary Self-catheterization) - Pain in Female Patients With Neurological Vesico-sphincter Disorders

Withdrawn Last updated 7 October 2022
What this trial tests

trial testing GentleCath™ Air catheter in Spinal Cord Injuries. Withdrawn.

Timeline
31 May 2021
Primary endpoint
1 September 2021
1 October 2021

Quick facts

Lead sponsorConvaTec Inc.
StatusWithdrawn
Study typeOBSERVATIONAL
Start date31 May 2021
Primary completion1 September 2021
Estimated completion1 October 2021

Drugs / interventions tested

Conditions studied

Sponsor

ConvaTec Inc.

Who can join

18 and older, female only, with Spinal Cord Injuries or Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the rate of occurrence of urethral pain in female patients with neurological vesico-sphincter disorders whilst performing self-catheterization using GentleCath™ Air catheters.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Spinal Cord Injuries

Currently open trials in the same condition.

Other ConvaTec Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04847609.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing